A new trial highlights that the timing of chemoradiation and immunotherapy is crucial when treating limited-stage small cell ...

"Tumor behavior upon recurrence is often more aggressive, and patients may quickly exhaust safe and effective options for ...

After 19 weeks on daily oral HU6 treatment, people shed on average 2.9 kg (~6.3 lb) or 2.7% of their starting body weight ...

Bill Gates visiting TerraPower Isotopes, the subsidiary of the nuclear power company TerraPower that he helped found. Gates ...

Adding immunotherapy to chemoradiation therapy (CRT) for limited-stage small cell lung cancer (SCLC) failed to improve ...

Use of an approved radionuclide therapy for difficult-to-treat meningioma was associated with substantially improved ...

Former prime minister Boris Johnson considered launching an “aquatic raid” on a warehouse in the Netherlands to retrieve ...

Former British Prime Minister Boris Johnson has said he ordered military chiefs to plan a raid on a Dutch factory in March ...

Jefferies analyst Peter Welford maintained a Hold rating on AstraZeneca (AZN – Research Report) today and set a price target of £114.00.

AstraZeneca (AZN) and Daiichi Sanyko (DSKYF)(DSNKY) said the FDA has accepted their application with priority review for ...

Owkin has partnered with AstraZeneca to develop an AI gBRCA pre-screen solution for breast cancer. Takeaway Points Owkin has ...

The Israeli-American unicorn company ImmunAI has signed a multi-year cooperation agreement with the pharmaceutical giant ...